


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+7.89%
-5.07%
+2.33%
-3.33%
+24.15%
CRSP
CRISPR Therapeutics
$54.89
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Investors confidence is positive
Chart
$68.29 (-19.62%)
$59.73 (-8.10%)
$44.43 (+23.54%)
$46.29 (+18.58%)
CRSP has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

CRSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CRSP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRSP Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayVCEL
38.63
-0.80%
IBRX
2.13
+0.23%
CLDI
1.41
-1.75%
BNTX
105.16
+1.95%
AMGN
322.32
+0.66%
What is CRSP current stock price?
What are CRSP stock strengths?
What risks are associated with CRSP stock?
When is CRSP next earnings report?
What is CRSP market cap and volume?
What is CRSP's current Stock IQ?
Should I buy CRSP stock right now?
Is CRSP a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRSP?
What does a 'Strong Sell' rating mean for CRSP?
What factors influence CRSP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+7.89%
-5.07%
+2.33%
-3.33%
+24.15%
CRSP
CRISPR Therapeutics
Current Price
$54.89
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Investors confidence is positive
Linked to CRSP
VCEL
38.63
-0.80%
IBRX
2.13
+0.23%
CLDI
1.41
-1.75%
BNTX
105.16
+1.95%
AMGN
322.32
+0.66%

Chart
$68.29 (-19.62%)
$59.73 (-8.10%)
$44.43 (+23.54%)
$46.29 (+18.58%)
CRSP Analysts Opinion
CRSP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CRSP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRSP Street Sentiment is bullish and have negative views on the near-term outlook
CRSP has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
CRSP Latest Analysis
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results. -Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medicine-
Today
CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note. The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16 representing a -2.56% change from its previous close.
Fri Nov 7, 2025
CRISPR Therapeutics Options Trading: A Deep Dive into Market Sentiment. Financial giants have made a conspicuous bearish move on CRISPR Therapeutics. Our analysis of options history for CRISPR Therapeutics (NASDAQ:CRSP) revealed 9 unusual trades.Delving into the details we found 33% of traders were ish while 44% showed bearish tendencies. Out of all the trades we spotted 4 were puts with a value of $169270 and 5 were calls valued at $277530.Analyzing the Volume and Open Interest in these contrac
Wed Nov 5, 2025
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It. Recently Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
Fri Oct 31, 2025
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?. CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue Oct 28, 2025
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Heres Why. In the closing of the recent trading day CRISPR Therapeutics AG (CRSP) stood at $67.21 denoting a 1.04% move from the preceding trading day.
Thu Oct 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRSP Stock trends
CRSP Stock performance
CRSP Stock analysis
CRSP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.